Alpha DNA Investment Management’s Invesco BulletShares 2023 Corporate Bond ETF BSCN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-300
Closed -$6K 758
2021
Q1
$6K Hold
300
0.01% 346
2020
Q4
$6K Buy
+300
New +$6.56K 0.01% 355

Other funds holding BSCN

Alpha DNA Investment Management's BSCN Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Invesco BulletShares 2023 Corporate Bond ETF (BSCN) in Q2 2021, closing a stake of 300 shares — an estimated $6K sold.

Alpha DNA Investment Management first reported a position in BSCN in Q4 2020 and held it in 2 quarters. The position peaked at $6K in Q1 2021. 264 funds tracked by Wall St. Rank hold BSCN as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Invesco BulletShares 2023 Corporate Bond ETF position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 300 Invesco BulletShares 2023 Corporate Bond ETF shares in Q2 2021, an estimated $6K.
  • Alpha DNA Investment Management first reported a position in Invesco BulletShares 2023 Corporate Bond ETF in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's Invesco BulletShares 2023 Corporate Bond ETF position peaked at $6K in Q1 2021.
  • 264 funds tracked by Wall St. Rank held Invesco BulletShares 2023 Corporate Bond ETF as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.